A Comprehensive Computational Analysis to Explore the Importance of SIGLECs in HCC Biology

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2023 Feb 21

PMID 36803349

Authors

Senbang Yao

Wenjun Chen

Tingting Chen

He Zuo

Ziran Bi

Xiuqing Zhang

Lulian Pang

Yanyan Jing

Xiangxiang Yin

Huaidong Cheng

Affiliations

Soon will be listed here.

Abstract

Background: Hepatocellular carcinoma (HCC) is an aggressive, malignant cancer with a complex pathogenesis. However, effective therapeutic targets and prognostic biomarkers are limited. Sorafenib provides delaying cancer progression and survival improvement in advanced HCC. But despite 10 years of research on the clinical application of sorafenib, predictive markers for its therapeutic effect are lacking.

Methods: The clinical significance and molecular functions of SIGLEC family members were assessed by a comprehensive bioinformatic analysis. The datasets included in this study (ICGC-LIRI-JP, GSE22058 and GSE14520) are mainly based on patients with HBV infections or HBV-related liver cirrhosis. The TCGA, GEO, and HCCDB databases were used to explore the expression of SIGLEC family genes in HCC. The Kaplan-Meier Plotter database was used to evaluate relationships between the expression levels of SIGLEC family genes and prognosis. Associations between differentially expressed genes in the SIGLEC family and tumour-associated immune cells were evaluated using TIMER.

Results: The mRNA levels of most SIGLEC family genes were significantly lower in HCC than in normal tissues. Low protein and mRNA expression levels of SIGLECs were strongly correlated with tumour grade and clinical cancer stage in patients with HCC. Tumour-related SIGLEC family genes were associated with tumour immune infiltrating cells. High SIGLEC expression was significantly related to a better prognosis in patients with advanced HCC treated with sorafenib.

Conclusions: SIGLEC family genes have potential prognostic value in HCC and may contribute to the regulation of cancer progression and immune cell infiltration. More importantly, our results revealed that SIGLEC family gene expression may be used as a prognostic marker for HCC patients treated with sorafenib.

Citing Articles

RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells.

Maggisano V, Capriglione F, Mio C, Bulotta S, Damante G, Russo D Int J Mol Sci. 2024; 25(3).

PMID: 38338696 PMC: 10855121. DOI: 10.3390/ijms25031407.

References

Abdu-Allah H, Watanabe K, Completo G, Sadagopan M, Hayashizaki K, Takaku C . CD22-antagonists with nanomolar potency: the synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold. Bioorg Med Chem. 2011; 19(6):1966-71. PMC: 3816717. DOI: 10.1016/j.bmc.2011.01.060. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

Bruix J, Cheng A, Meinhardt G, Nakajima K, De Sanctis Y, Llovet J . Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies. J Hepatol. 2017; 67(5):999-1008. DOI: 10.1016/j.jhep.2017.06.026. View

Thul P, Akesson L, Wiking M, Mahdessian D, Geladaki A, Blal H . A subcellular map of the human proteome. Science. 2017; 356(6340). DOI: 10.1126/science.aal3321. View

Barkal A, Brewer R, Markovic M, Kowarsky M, Barkal S, Zaro B . CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019; 572(7769):392-396. PMC: 6697206. DOI: 10.1038/s41586-019-1456-0. View

Bornhofft K, Viergutz T, Kuhnle A, Galuska S . Nanoparticles Equipped with α2,8-Linked Sialic Acid Chains Inhibit the Release of Neutrophil Extracellular Traps. Nanomaterials (Basel). 2019; 9(4). PMC: 6523985. DOI: 10.3390/nano9040610. View

Muenst S, Laubli H, Soysal S, Zippelius A, Tzankov A, Hoeller S . The immune system and cancer evasion strategies: therapeutic concepts. J Intern Med. 2016; 279(6):541-62. DOI: 10.1111/joim.12470. View

Sun J, Lu Q, Sanmamed M, Wang J . Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy. Clin Cancer Res. 2020; 27(3):680-688. PMC: 9942711. DOI: 10.1158/1078-0432.CCR-19-2925. View

10.

Yang C, Huang X, Liu Z, Qin W, Wang C . Metabolism-associated molecular classification of hepatocellular carcinoma. Mol Oncol. 2020; 14(4):896-913. PMC: 7138397. DOI: 10.1002/1878-0261.12639. View

11.

Zhu C, Wang A, Zhang H, Wan X, Yang X, Chen S . Research progress and prospects of markers for liver cancer stem cells. World J Gastroenterol. 2015; 21(42):12190-6. PMC: 4641136. DOI: 10.3748/wjg.v21.i42.12190. View

12.

Pinero J, Sauch J, Sanz F, Furlong L . The DisGeNET cytoscape app: Exploring and visualizing disease genomics data. Comput Struct Biotechnol J. 2021; 19:2960-2967. PMC: 8163863. DOI: 10.1016/j.csbj.2021.05.015. View

13.

Jiang Y, Tie C, Wang Y, Bian D, Liu M, Wang T . Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis. Front Oncol. 2020; 10:1759. PMC: 7506152. DOI: 10.3389/fonc.2020.01759. View

14.

Macauley M, Crocker P, Paulson J . Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol. 2014; 14(10):653-66. PMC: 4191907. DOI: 10.1038/nri3737. View

15.

Liao Y, Wang J, Jaehnig E, Shi Z, Zhang B . WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019; 47(W1):W199-W205. PMC: 6602449. DOI: 10.1093/nar/gkz401. View

16.

Guo L, Sharma S, Debes J, Beisang D, Rattenbacher B, Vlasova-St Louis I . The hepatitis C viral nonstructural protein 5A stabilizes growth-regulatory human transcripts. Nucleic Acids Res. 2018; 46(5):2537-2547. PMC: 5861452. DOI: 10.1093/nar/gky061. View

17.

Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

18.

Nagy A, Munkacsy G, Gyorffy B . Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021; 11(1):6047. PMC: 7961001. DOI: 10.1038/s41598-021-84787-5. View

19.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

20.

Tao L, Wang S, Yang L, Jiang L, Li J, Wang X . Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma. Clin Exp Immunol. 2020; 201(2):161-170. PMC: 7366747. DOI: 10.1111/cei.13444. View